Welcome to our dedicated page for Lifeway Food news (Ticker: LWAY), a resource for investors and traders seeking the latest updates and insights on Lifeway Food stock.
Lifeway Foods, Inc. (NASDAQ: LWAY), the leading U.S. producer of probiotic kefir and fermented dairy products, provides this centralized hub for official company announcements and market developments. Investors and industry followers will find timely updates on financial results, product innovations, and strategic initiatives driving growth in the functional foods sector.
This resource aggregates all essential LWAY news, including quarterly earnings disclosures, manufacturing expansions, new product launches like probiotic-infused beverages, and distribution partnerships across domestic and international markets. Content is curated to help stakeholders track operational milestones and regulatory filings while maintaining compliance with financial disclosure standards.
Key news categories include financial performance updates, retail distribution agreements, R&D advancements in gut-health products, and sustainability initiatives. The archive serves as both a historical record and real-time tracking tool for Lifeway's position in the $50B global probiotic market.
Bookmark this page for streamlined access to verified Lifeway Foods updates. Combine these official releases with broader market analysis to inform your understanding of this innovative health-focused dairy producer.
Lifeway Foods (NASDAQ: LWAY) faces internal turmoil as Edward and Ludmila Smolyansky, who own 28% of shares, protest the dismissal of Amy Feldman, Senior Executive VP of Sales, on February 28, 2025. The firing occurs amid controversy over CEO Julie Smolyansky's recent compensation package, including a $2 million cash bonus and 283,337 shares valued at $6.5 million, representing 94% of the company's 2024 net income.
The share award is currently under litigation due to lack of required consent from major investor Danone North America. Edward and Ludmila Smolyansky demand
- Transparency regarding Feldman's termination
- Rescission of CEO's share award
- Distribution of equity to employees
- Release of Q1 2025 financial reports
The Smolyanskys have submitted a full slate of Board nominees for the 2025 Annual Meeting, pushing for leadership changes and improved governance.
Lifeway Foods (NASDAQ: LWAY) anticipates a $5 million net gain from the sale of Simple Mills to Flowers Foods, following their early investment in 2015. The total expected proceeds for Lifeway will reach $6.5 million, including a previously realized gain of $1.5 million in 2019.
The acquisition deal values Simple Mills at $795 million and is expected to close in Q1 2025, subject to regulatory approval. Lifeway's Board of Directors has expressed support for CEO Julie Smolyansky, who was responsible for the initial Simple Mills investment decision.
Lifeway Foods (NASDAQ: LWAY), a leading U.S. supplier of Kefir and fermented probiotic products, has responded to Edward Smolyansky's nomination of seven candidates to replace the company's entire Board of Directors at the 2025 annual meeting. The company notes that Smolyansky was previously terminated for cause as an officer.
The announcement comes after Lifeway reported record full-year earnings for 2024 and achieved its 22nd consecutive quarter of growth. The company's Audit and Corporate Governance Committee will review the nominees, and the Board will make recommendations in due course.
Lifeway maintains its focus on business opportunities and momentum, expressing confidence in continued growth driven by increasing consumer interest in microbiome health and the gut-brain connection. The company has expanded its presence across multiple international markets, including Mexico, Ireland, South Africa, UAE, and France.
Edward Smolyansky, along with Ludmila Smolyansky, who together own 4,163,141 shares of Lifeway Foods (NASDAQ: LWAY), has initiated a campaign to replace the company's Board of Directors. The move comes amid governance concerns and legal challenges, including a lawsuit from Danone, Lifeway's largest unaffiliated investor.
The campaign follows controversial decisions by the current board, including a $8.5 million CEO compensation package comprising a $2 million cash bonus and 283,337 shares granted to CEO Julie Smolyansky - representing over 94% of Lifeway's 2024 net income. Additionally, the board rejected Danone's unsolicited offer to acquire remaining shares at $27 per share, a 72% premium over the 3-month volume weighted average price.
The proposed new slate includes George Sent, a food and beverage industry investment banker, Edward Smolyansky, and company co-founder Ludmila Smolyansky, aiming to evaluate strategic alternatives and maximize shareholder value.
Lifeway Foods (LWAY) reported record-breaking financial results for Q4 and full year 2024, with annual net sales reaching $186.8 million, marking a 17% year-over-year increase. The company achieved its 21st consecutive quarter of year-over-year growth, with Q4 net sales of $46.9 million.
Key financial highlights for FY2024 include:
- Gross profit margin of 26.0%
- SG&A expenses at 18.3% of net sales
- Net income of $9.0 million
- Earnings per share of $0.61 basic and $0.60 diluted
The company's growth was primarily driven by increased volumes of branded drinkable kefir products. Lifeway is expanding its production capabilities with upgrades at its Waukesha facility, which will nearly double production capacity and triple bottling speed. The company maintains its guidance for Adjusted EBITDA of $45-50 million by FY2027.
Lifeway Foods (NASDAQ: LWAY) has issued a statement responding to Danone's (OTCQX: DANOY) recent actions, including a lawsuit filed with the SEC. Lifeway characterizes these moves as part of a hostile takeover attempt at an undervalued price.
The company highlights tensions dating back to Danone's 1999 investment, citing issues such as Danone's resistance to executive compensation and competitive behaviors. Lifeway states that Danone has leveraged a 1999 Stockholders' Agreement, which Lifeway considers invalid, to its advantage at shareholders' expense.
On the business front, Lifeway reports strong performance with record full-year unaudited 2024 results in revenue, net income, and EBITDA. The company also achieved 17% year-over-year sales growth in the last week of February 2025, reaching $4,543,297 compared to $3,880,625 in the same period of 2024. Lifeway plans to file a counterclaim against Danone.
Lifeway Foods (Nasdaq: LWAY) announced that CEO Julie Smolyansky will join Katie Couric at SXSW on March 8th, 2025, to discuss gut health trends and the company's history. The event will take place at 10:15am at the She Media Lounge in Austin, TX.
The discussion comes amid new research from Mass General Brigham showing that consuming two or more servings of fermented dairy weekly led to a 20% reduction in Bifidobacterium-positive colorectal cancer incidence over three decades. The study highlights the potential benefits of live bacterial cultures in fermented milk products for gut health and cancer risk reduction.
As America's leading kefir supplier, Lifeway Kefir contains 12 live and active cultures, protein, calcium, and vitamin D, supporting overall wellness and gut flora balance.
Lifeway Foods (LWAY) will showcase new product innovations at Natural Products Expo West 2025, taking place March 4th-7th in Anaheim. The company will present its new probiotic salad dressing concepts and conventional whole milk kefir flavors, complementing their organic whole milk kefir line.
Visitors will have the opportunity to sample recently launched products including Lactose-Free Flavor Fusions and Probiotic Smoothies + Collagen. The exhibition will feature kefir parfaits and farmer cheese appetizers, highlighting the product's versatility and protein content.
CEO Julie Smolyansky emphasized the company's focus on developing products that align with consumer demands, particularly noting growing interest in kefir due to research linking fermented milk products to reduced colorectal cancer incidence. The new offerings feature on-trend ingredients and fusion flavors targeting Gen Z and Millennial shoppers while maintaining the company's standard of high-quality, bioavailable nutrients.
Lifeway Foods (Nasdaq: LWAY) announced the distribution of its Farmer Cheese to 1,400 Albertsons stores across the U.S. The product is a premium cultured soft cheese made with a small batch, artisanal recipe featuring 12 live and active probiotics and 15g of protein per serving.
The Farmer Cheese spreads like cream cheese and has a texture similar to blended cottage cheese. It is up to 99% lactose-free, gluten-free, contains no added salt, and is high in calcium. The company reports increasing consumer interest, partly driven by social media influence and viral recipes using blended cottage cheese.
This expansion represents a significant step in Lifeway's strategy to introduce the product to new audiences, building on their established position as a leading U.S. supplier of kefir and fermented probiotic products.
Lifeway Foods (NASDAQ: LWAY) anticipates a $5 million net gain from the sale of Simple Foods to Flowers Foods. This gain stems from Lifeway's early investment in Simple Mills in 2015. The company had previously realized a $1.5 million gain in 2019, bringing the total expected proceeds to approximately $6.5 million.
The acquisition of Simple Mills by Flowers Foods, valued at $795 million, is pending regulatory approval and expected to close in Q1 2025. Lifeway's Board of Directors has expressed support for CEO Julie Smolyansky, who was responsible for the initial investment decision in Simple Mills.
